{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:26:55Z","timestamp":1787020015299,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 81770342"],"award-info":[{"award-number":["NSFC 81770342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Health and Family Planning Commission","award":["YKK16124"],"award-info":[{"award-number":["YKK16124"]}]},{"name":"Nanjing health youth talent training project","award":["QRX17017"],"award-info":[{"award-number":["QRX17017"]}]},{"name":"Nanjing Municipal Commission of Science & Technology","award":["201715026"],"award-info":[{"award-number":["201715026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0841-1","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T07:17:24Z","timestamp":1527146244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiao-Fei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Feng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Quan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Yang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2710-8516","authenticated-orcid":false,"given":"Jun-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"issue":"17","key":"841_CR1","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126\u201330.","journal-title":"JAMA"},{"issue":"1","key":"841_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","volume":"122","author":"T Kimura","year":"2010","unstructured":"Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the registry of stent thrombosis for review and reevaluation (RESTART). Circulation. 2010;122(1):52\u201361.","journal-title":"Circulation"},{"issue":"9892","key":"841_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","volume":"382","author":"GW Stone","year":"2013","unstructured":"Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet. 2013;382(9892):614\u201323.","journal-title":"Lancet"},{"issue":"4","key":"841_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1055\/s-0037-1617137","volume":"29","author":"D Capodanno","year":"2009","unstructured":"Capodanno D, Angiolillo DJ. Platelet monitoring for PCI: which test is the one to choose? Hamostaseologie. 2009;29(4):376\u201380.","journal-title":"Hamostaseologie"},{"issue":"19","key":"841_CR5","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","volume":"50","author":"PA Gurbel","year":"2007","unstructured":"Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(19):1822\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"10055","key":"841_CR6","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","volume":"388","author":"G Cayla","year":"2016","unstructured":"Cayla G, Cuisset T, Silvain J, Leclercq F, Manzo-Silberman S, Saint-Etienne C, Delarche N, Bellemain-Appaix A, Range G, El Mahmoud R, et al. Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial. Lancet. 2016;388(10055):2015\u201322.","journal-title":"Lancet"},{"issue":"22","key":"841_CR7","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"JP Collet","year":"2012","unstructured":"Collet JP, Cuisset T, Range G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrie D, Boueri Z, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med. 2012;367(22):2100\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"841_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","volume":"124","author":"MJ Price","year":"2011","unstructured":"Price MJ, Angiolillo DJ, Teirstein PS, Lillie E, Manoukian SV, Berger PB, Tanguay JF, Cannon CP, Topol EJ. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the gauging responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial. Circulation. 2011;124(10):1132\u20137.","journal-title":"Circulation"},{"issue":"24","key":"841_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"D Trenk","year":"2012","unstructured":"Trenk D, Stone GW, Gawaz M, Kastrati A, Angiolillo DJ, Muller U, Richardt G, Jakubowski JA, Neumann FJA. Randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on Clopidogrel to guide alternative therapy with Prasugrel) study. J Am Coll Cardiol. 2012;59(24):2159\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"841_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","volume":"35","author":"D Aradi","year":"2014","unstructured":"Aradi D, Storey RF, Komocsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J. 2014;35(4):209\u201315.","journal-title":"Eur Heart J"},{"issue":"11","key":"841_CR11","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jcin.2013.06.010","volume":"6","author":"C Viviani Anselmi","year":"2013","unstructured":"Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC Cardiovasc Interv. 2013;6(11):1166\u201375.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"841_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12872-016-0394-0","volume":"16","author":"JJ Zhang","year":"2016","unstructured":"Zhang JJ, Gao XF, Ge Z, Tian NL, Liu ZZ, Lin S, Ye F, Chen SL. High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16(1):240.","journal-title":"BMC Cardiovasc Disord"},{"key":"841_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.10.022","volume":"250","author":"B Redfors","year":"2018","unstructured":"Redfors B, Genereux P, Witzenbichler B, Kirtane AJ, Maehara A, Weisz G, Madhavan MV, McAndrew T, Mehran R, Stone GW. Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. Int J Cardiol. 2018;250:92\u20137.","journal-title":"Int J Cardiol"},{"issue":"16","key":"841_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jcin.2017.05.059","volume":"10","author":"TD Stuckey","year":"2017","unstructured":"Stuckey TD, Kirtane AJ, Brodie BR, Witzenbichler B, Litherland C, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, et al. Impact of aspirin and Clopidogrel Hyporesponsiveness in patients treated with drug-eluting stents: 2-year results of a prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017;10(16):1607\u201317.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"841_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/09537104.2013.865835","volume":"26","author":"J Guan","year":"2015","unstructured":"Guan J, Cong Y, Ren J, Zhu Y, Li L, Deng X, Bai J. Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals. Platelets. 2015;26(1):25\u201330.","journal-title":"Platelets"},{"issue":"20","key":"841_CR16","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","volume":"28","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD. Joint ESCAAHAWHFTFftRoMI. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525\u201338.","journal-title":"Eur Heart J"},{"issue":"23","key":"841_CR17","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"17","key":"841_CR18","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351.","journal-title":"Circulation"},{"issue":"6","key":"841_CR19","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1161\/01.CIR.88.6.2987","volume":"88","author":"TJ Ryan","year":"1993","unstructured":"Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB 3rd, McCallister BD, Smith SC Jr, Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association\/American College of Cardiology Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on percutaneous transluminal coronary angioplasty). Circulation. 1993;88(6):2987\u20133007.","journal-title":"Circulation"},{"issue":"6","key":"841_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1182\/blood-2017-03-742338","volume":"130","author":"AD Michelson","year":"2017","unstructured":"Michelson AD, Bhatt DL. How I use laboratory monitoring of antiplatelet therapy. Blood. 2017;130(6):713\u201321.","journal-title":"Blood"},{"issue":"17","key":"841_CR21","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1517\/14656566.2014.968126","volume":"15","author":"US Tantry","year":"2014","unstructured":"Tantry US, Gesheff M, Liu F, Bliden KP, Gurbel PA. Resistance to antiplatelet drugs: what progress has been made? Expert Opin Pharmacother. 2014;15(17):2553\u201364.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"841_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1074248417728287","volume":"23","author":"DA Dezsi","year":"2018","unstructured":"Dezsi DA, Merkely B, Skopal J, Barabas E, Varnai K, Falukozy J, Veress G, Alotti N, Aradi D. Impact of test conditions on ADP-induced platelet function results with the multiplate assay: is further standardization required? J Cardiovasc Pharmacol Ther. 2018;23(2):149\u201354.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"841_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1074248415581175","volume":"21","author":"V Ignjatovic","year":"2016","unstructured":"Ignjatovic V, Pavlovic S, Miloradovic V, Andjelkovic N, Davidovic G, Djurdjevic P, Stolic R, Iric-Cupic V, Simic I, Ignjatovic VD, et al. Influence of different beta-blockers on platelet aggregation in patients with coronary artery disease on dual antiplatelet therapy. J Cardiovasc Pharmacol Ther. 2016;21(1):44\u201352.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"841_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357.","journal-title":"N Engl J Med"},{"issue":"20","key":"841_CR25","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315.","journal-title":"N Engl J Med"},{"issue":"23","key":"841_CR26","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","volume":"32","author":"RC Becker","year":"2011","unstructured":"Becker RC, Bassand JP, Budaj A, Wojdyla DM, James SK, Cornel JH, French J, Held C, Horrow J, Husted S, et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2011;32(23):2933\u201344.","journal-title":"Eur Heart J"},{"issue":"41","key":"841_CR27","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","volume":"38","author":"T Cuisset","year":"2017","unstructured":"Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert M, et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. Eur Heart J. 2017;38(41):3070\u20138.","journal-title":"Eur Heart J"},{"issue":"10","key":"841_CR28","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4244\/EIJ-D-17-00634","volume":"13","author":"P Zocca","year":"2017","unstructured":"Zocca P, van der Heijden LC, Kok MM, Lowik MM, Hartmann M, Stoel MG, Louwerenburg JW, de Man F, Linssen GCM, Knottnerus IL, et al. Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT. EuroIntervention. 2017;13(10):1168\u201376.","journal-title":"EuroIntervention"},{"issue":"23","key":"841_CR29","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/eurheartj\/ehn419","volume":"29","author":"M Lordkipanidze","year":"2008","unstructured":"Lordkipanidze M, Pharand C, Nguyen TA, Schampaert E, Palisaitis DA, Diodati JG. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J. 2008;29(23):2877\u201385.","journal-title":"Eur Heart J"},{"issue":"7","key":"841_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/09537104.2013.840363","volume":"25","author":"G Lemesle","year":"2014","unstructured":"Lemesle G, Landel JB, Bauters A, Delhaye C, Bonello L, Sudre A, Susen S, Bauters C, Lablanche JM. Poor agreement between light transmission aggregometry, verify now P2Y(1)(2) and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: a potential explanation of negative results of recent randomized trials. Platelets. 2014;25(7):499\u2013505.","journal-title":"Platelets"},{"issue":"5","key":"841_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11936-014-0300-y","volume":"16","author":"F Franchi","year":"2014","unstructured":"Franchi F, Rollini F, Cho JR, Ferrante E, Angiolillo DJ. Platelet function testing in contemporary clinical and interventional practice. Curr Treat Options Cardiovasc Med. 2014;16(5):300.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"841_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/VHRM.S44469","volume":"11","author":"R Paniccia","year":"2015","unstructured":"Paniccia R, Priora R, Liotta AA, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag. 2015;11:133\u201348.","journal-title":"Vasc Health Risk Manag"},{"issue":"10104","key":"841_CR33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","volume":"390","author":"D Sibbing","year":"2017","unstructured":"Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Hadamitzky M, Merkely B, Kiss RG, et al. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017;390(10104):1747\u201357.","journal-title":"Lancet"},{"key":"841_CR34","doi-asserted-by":"publisher","unstructured":"Tang Y-D, Wang W, Yang M, Zhang K, Chen J, Qiao S, Yan H, Wu Y, Huang X, Xu B, et al. Randomized comparisons of double-dose Clopidogrel or adjunctive Cilostazol versus standard dual Anti-platelet in patients with high post-treatment platelet reactivity: results of the CREATIVE trial (Clopidogrel response evaluation and AnTi-platelet InterVEntion in high thrombotic risk PCI patients). Circulation. 2018. PMID:29420189. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030190\n                    \n                  .","DOI":"10.1161\/CIRCULATIONAHA.117.030190"},{"issue":"15","key":"841_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","volume":"167","author":"JD Snoep","year":"2007","unstructured":"Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med. 2007;167(15):1593\u20139.","journal-title":"Arch Intern Med"},{"issue":"6","key":"841_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","volume":"69","author":"DL Bhatt","year":"2017","unstructured":"Bhatt DL, Grosser T, Dong JF, Logan D, Jeske W, Angiolillo DJ, Frelinger AL 3rd, Lei L, Liang J, Moore JE, et al. Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2017;69(6):603\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"841_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","volume":"127","author":"T Grosser","year":"2013","unstructured":"Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation. 2013;127(3):377\u201385.","journal-title":"Circulation"},{"issue":"1","key":"841_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","volume":"66","author":"C Patrono","year":"2015","unstructured":"Patrono C. The multifaceted clinical readouts of platelet inhibition by low-dose aspirin. J Am Coll Cardiol. 2015;66(1):74\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"841_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/clc.22540","volume":"39","author":"MH Kim","year":"2016","unstructured":"Kim MH, Choi SY, An SY, Serebruany V. Validation of three platelet function tests for bleeding risk stratification during dual antiplatelet therapy following coronary interventions. Clin Cardiol. 2016;39(7):385\u201390.","journal-title":"Clin Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0841-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:12:00Z","timestamp":1558638720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0841-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional ethics committee of Nanjing First Hospital, and was carried out in accordance with the guidelines of the Declaration of Helsinki. Written informed consent was formally obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"103"}}